Publication Name	World Journal of Hepatology
Manuscript ID	77963
Country	Spain

Received	2022-05-30 11:33
Peer-Review Started	2022-05-30 11:36
To Make the First Decision
Return for Revision	2022-07-06 22:55
Revised	2022-07-07 12:05
Second Decision	2022-08-29 03:59
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-08-30 20:48
Articles in Press	2022-08-30 20:48
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-08-22 00:59
Typeset the Manuscript	2022-09-02 07:30
Publish the Manuscript Online	2022-09-23 00:48

ISSN	1948-5182 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Letter to the Editor
Article Title	Analysis of hepatitis C virus positive organs in liver transplantation.
Manuscript Source	Unsolicited Manuscript
All Author List	Isabel Legaz and Manuel Muro
ORCID	Author(s) ORCID Number Isabel Legaz http://orcid.org/0000-0002-1140-4313 Manuel Muro http://orcid.org/0000-0001-9987-0994
Funding Agency and Grant Number
Corresponding Author	Isabel Legaz, PhD, Senior Lecturer, Department of Legal and Forensic Medicine, Biomedical Research Institute, Regional Campus of International Excellence "Campus Mare Nostrum", Faculty of Medicine, University of Murcia, Espinardo, Murcia 30100, Spain. isalegaz@um.es
Key Words	Hepatitis C virus; Liver transplant; Graft Survival; United Network for Organ Sharing; Direct-acting antiviral
Core Tip	The scarcity of viable organs, which is actually quite limited, the waiting lists that reflect chronicity and the increase in time to transplantation, and the rate of physical deterioration resulting in death while waiting for a helpful organ for transplantation, promote the search for new ways, strategies and protocols to increase the group of donors acceptable for transplantation, such as donors in asystole, donors with tumor processes or donors with previous infection the application of antivirals against the hepatitis C virus, with unprecedented success in the elimination of the pathogen has led to the use of HCV+ donors as optimal donors for HCV negative recipients, with survival similar to that of both HCV negative donors and recipients, which supports the use of these HCV+ donors without restrictions.
Publish Date	2022-09-23 00:48
Citation	Legaz I, Muro M. Analysis of hepatitis C virus-positive organs in liver transplantation. World J Hepatol 2022; 14(9): 1840-1843
URL	https://www.wjgnet.com/1948-5182/full/v14/i9/1840.htm
DOI	https://dx.doi.org/10.4254/wjh.v14.i9.1840

Full Article (PDF)	WJH-14-1840.pdf
Full Article (Word)	WJH-14-1840.docx
Manuscript File	77963_Auto_Edited-LM.docx
Answering Reviewers	77963-Answering reviewers.pdf
Audio Core Tip	77963-Audio core tip.wav
Conflict-of-Interest Disclosure Form	77963-Conflict-of-interest statement.pdf
Copyright License Agreement	77963-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	77963-Language certificate.pdf
Peer-review Report	77963-Peer-review(s).pdf
Scientific Misconduct Check	77963-Bing-Wang LL-2.png
Scientific Editor Work List	77963-Scientific editor work list.pdf
CrossCheck Report	77963-CrossCheck report.pdf